{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:46:07Z","timestamp":1773855967051,"version":"3.50.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Information on clinical characteristics of heart failure (HF) among Africans with hypertension is needed to help define the burden of hypertension in this population, but currently there is little data available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To determine the clinical characteristics of HF, related risk factors and co-morbidities among adult Cameroonians treated for hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Medical files of 1218 patients with hypertension followed at the cardiac clinic of Yaounde General Hospital were evaluated over a 10-year period from 1995 to 2005. One hundred and forty (11.5%) patients with clinical HF or asymptomatic left ventricular dysfunction were included in the present analysis. Ages ranged from 26 to 84 years (mean 54.9 years) and 86 (61.4%) were men. Systolic dysfunction and isolated diastolic HF were found in 64% and 23% of patients, respectively. Seventy nine (56.4%) patients had at least one co-morbidity and 43 (30.7%) had multiple co-morbidities. Co-morbidities included: renal impairment (24.3%), overweight and obesity (20.7%), chronic obstructive pulmonary disease (17.1%), gout (16.4%), anaemia (15.7), diabetes mellitus (13.5%), atrial fibrillation (12.9%), stroke (9.3%), and ischaemic heart disease (5.7%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HF is frequent among Cameroonian patients treated for hypertension and is regularly associated with co-morbidities. Efforts are needed to improve the control of hypertension and enhance early detection of these co-morbidities in this context.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.ejheart.2008.02.009","type":"journal-article","created":{"date-parts":[[2008,3,21]],"date-time":"2008-03-21T00:51:42Z","timestamp":1206060702000},"page":"367-372","source":"Crossref","is-referenced-by-count":26,"title":["Chronic Heart Failure, Selected Risk Factors and Co-Morbidities Among Adults Treated for Hypertension in a Cardiac Referral Hospital in Cameroon"],"prefix":"10.1093","volume":"10","author":[{"given":"Anastase","family":"Dzudie","sequence":"first","affiliation":[{"name":"Heart failure and transplantation Unit, Louis Pradel's Cardiovascular Hospital , Lyon ,","place":["France"]},{"name":"Department of Internal medicine and subspecialties, University of Yaound\u00e9 I \u00a0","place":["Cameroon"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre Pascal","family":"Kengne","sequence":"additional","affiliation":[{"name":"The George Institute For International Health, University of Sydney \u00a0","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salomon","family":"Mbahe","sequence":"additional","affiliation":[{"name":"Department of Internal medicine and subspecialties, University of Yaound\u00e9 I \u00a0","place":["Cameroon"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Menanga","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Service of Internal Medicine B, Yaound\u00e9 General Hospital \u00a0","place":["Cameroon"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Kenfack","sequence":"additional","affiliation":[{"name":"Department of Internal medicine and subspecialties, University of Yaound\u00e9 I \u00a0","place":["Cameroon"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Kingue","sequence":"additional","affiliation":[{"name":"Department of Internal medicine and subspecialties, University of Yaound\u00e9 I \u00a0","place":["Cameroon"]},{"name":"Cardiology Unit, Service of Internal Medicine B, Yaound\u00e9 General Hospital \u00a0","place":["Cameroon"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,1,13]]},"reference":[{"key":"2026020203432284300_ejhf2008-02-009-bib-0001","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/oxfordjournals.eurheartj.a015223","article-title":"The epidemiology of heart failure","volume":"18","author":"Cowie","year":"1997","journal-title":"Eur Heart J"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0002","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0167-5273(01)00497-1","article-title":"The epidemiological features of heart failure in developing countries: a review of the literature","volume":"80","author":"Mendez","year":"2001","journal-title":"Int J Cardiol"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0003","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1161\/CIRCULATIONAHA.105.542894","article-title":"Epidemiology and etiology of cardiomyopathy in Africa","volume":"112","author":"Sliwa","year":"2005","journal-title":"Circulation"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000006996","article-title":"Aetiology of heart failure as seen from a National Cardiac Referral Centre in Africa","volume":"93","author":"Amoah","year":"2000","journal-title":"Cardiology"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ancard.2005.04.014","article-title":"Nouveau regard sur l'insuffisance cardiaque chronique de l'adulte en Afrique \u00e0 l'\u00e8re de l'Echocardiographie Doppler: Exp\u00e9rience du service de m\u00e9decine de l'H\u00f4pital G\u00e9n\u00e9ral de Yaound\u00e9","volume":"54","author":"Kingue","year":"2005","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0006","first-page":"217","article-title":"Cardiac insufficiency in the African cardiology milieu. 57","volume":"96","author":"Thiam","year":"2003","journal-title":"Bull Soc Pathol Exot"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0007","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/01.hjh.0000209973.67746.f0","article-title":"Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden","volume":"24","author":"Lawes","year":"2006","journal-title":"J Hypertens"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0008","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.hjh.0000199801.72563.6f","article-title":"Blood pressure and the global burden of disease 2000: Part 1:estimates of blood pressure level","volume":"3","author":"Lawes","year":"2006","journal-title":"J Hum Hypertens"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0009","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1161\/CIRCULATIONAHA.105.539569","article-title":"Hypertension in Sub-Saharan African populations","volume":"112","author":"Opie","year":"2007","journal-title":"Circulation"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(07)70002-9","article-title":"Burden of stroke in black populations in sub-Saharan Africa","volume":"6","author":"Connor","year":"2007","journal-title":"Lancet Neurol"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0011","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1747-4949.2006.00064.x","article-title":"The neglected burden of stroke in Sub-Saharan Africa","volume":"1","author":"Kengne","year":"2006","journal-title":"Int J Stroke"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0012","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0013","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","article-title":"Natural history of asymptomatic left ventricular systolic dysfunction in the community","volume":"108","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0014","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure (JNC VI)","volume":"157","author":"Anonymous","year":"1997","journal-title":"Arch Int Med"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0015","first-page":"89","article-title":"Target organ damage and associated clinical conditions among Nigerians with treated hypertension","volume":"16","author":"Ayodele","year":"2005","journal-title":"Cardiovasc J South Afr"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0016","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","article-title":"Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort","volume":"33","author":"Vasan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0017","first-page":"968","article-title":"Diastolic dysfunction in persons with hypertensive heart failure","volume":"96","author":"Oyati","year":"2004","journal-title":"J Natl Med Assoc"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0018","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0002-9149(99)00773-0","article-title":"Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint","volume":"85","author":"Wachtell","year":"2000","journal-title":"Am J Cardiol"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0019","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ejheart.2004.03.011","article-title":"Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe","volume":"6","author":"Muntwyler","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0020","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(05)67760-4","article-title":"Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial","volume":"366","author":"Granger","year":"2005","journal-title":"Lancet"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0021","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0022","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0023","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.jacc.2004.07.040","article-title":"Renal insufficiency as an independent predictor of mortality among women with heart failure","volume":"44","author":"Bibbins-Domingo","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0024","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5414\/CNP61177","article-title":"Renal dysfunction in congestive heart failure, pathophysiological and prognostic significance","volume":"61","author":"Cohen","year":"2004","journal-title":"Clin Nephrol"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0025","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1161\/01.CIR.0000142047.28024.F2","article-title":"Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial","volume":"110","author":"Aguilar","year":"2004","journal-title":"Circulation"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0026","first-page":"536","article-title":"Congestive heart failure and diabetes mellitus","volume":"60","author":"Ancion","year":"2005","journal-title":"Rev Med Liege"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0027","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0002-9343(03)00392-9","article-title":"Functional class in patients with heart failure is associated with the development of diabetes","volume":"115","author":"Bell","year":"2003","journal-title":"Am J Med"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0028","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1527-5299.2003.01388.x","article-title":"Treatment of heart failure in older persons. Dilemmas with coexisting conditions: diabetes mellitus, chronic obstructive pulmonary disease, and arthritis","volume":"9","author":"Aronow","year":"2003","journal-title":"Congest Heart Fail"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0029","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jacc.2006.08.046","article-title":"Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure","volume":"49","author":"Le Jemtel","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0030","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ejheart.2004.09.003","article-title":"Aetiology, comorbidity and drug therapy of chronic heart failure in the real world: the EPICA substudy","volume":"6","author":"Ceia","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0031","first-page":"209","article-title":"Epidemiology of atrial fibrillation in patients hospitalized in a large hospital","volume":"35","author":"Ali","year":"1993","journal-title":"Panminerva Med"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0032","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pcad.2005.09.001","article-title":"Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment","volume":"48","author":"Heist","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"key":"2026020203432284300_ejhf2008-02-009-bib-0033","first-page":"38","article-title":"The burden of high blood pressure and related risk factors in urban sub-Saharan Africa: Evidences from Douala in Cameroon","volume":"7","author":"Kengne","year":"2007","journal-title":"Afr. Health Sci"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ejheart.2008.02.009","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/10\/4\/367\/66563756\/eurjhf_10_4_367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/10\/4\/367\/66563756\/eurjhf_10_4_367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:43:33Z","timestamp":1770021813000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/10\/4\/367\/8439894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,1,13]]},"published-print":{"date-parts":[[2008,4,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ejheart.2008.02.009","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,4]]},"published":{"date-parts":[[2008,4,1]]}}}